These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23826311)

  • 1. Seminal plasma as a source of prostate cancer peptide biomarker candidates for detection of indolent and advanced disease.
    Neuhaus J; Schiffer E; von Wilcke P; Bauer HW; Leung H; Siwy J; Ulrici W; Paasch U; Horn LC; Stolzenburg JU
    PLoS One; 2013; 8(6):e67514. PubMed ID: 23826311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-omics Biomarker Pipeline Reveals Elevated Levels of Protein-glutamine Gamma-glutamyltransferase 4 in Seminal Plasma of Prostate Cancer Patients.
    Drabovich AP; Saraon P; Drabovich M; Karakosta TD; Dimitromanolakis A; Hyndman ME; Jarvi K; Diamandis EP
    Mol Cell Proteomics; 2019 Sep; 18(9):1807-1823. PubMed ID: 31249104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of two gene panels for prostate cancer diagnosis and patient risk stratification.
    Xiao K; Guo J; Zhang X; Feng X; Zhang H; Cheng Z; Johnson H; Persson JL; Chen L
    Tumour Biol; 2016 Aug; 37(8):10115-22. PubMed ID: 26820133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics in diagnosis of prostate cancer.
    Davalieva K; Polenakovic M
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):5-36. PubMed ID: 26076772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seminal plasma metabolomics reveals lysine and serine dysregulation as unique features distinguishing between prostate cancer tumors of Gleason grades 6 and 7.
    Falegan OS; Jarvi K; Vogel HJ; Hyndman ME
    Prostate; 2021 Aug; 81(11):713-720. PubMed ID: 34097313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis.
    Barceló M; Castells M; Bassas L; Vigués F; Larriba S
    Sci Rep; 2019 Sep; 9(1):13772. PubMed ID: 31551516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative urinary proteomics using stable isotope labelling by peptide dimethylation in patients with prostate cancer.
    Li C; Zang T; Wrobel K; Huang JT; Nabi G
    Anal Bioanal Chem; 2015 May; 407(12):3393-404. PubMed ID: 25724369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia.
    Kawahara R; Recuero S; Nogueira FCS; Domont GB; Leite KRM; Srougi M; Thaysen-Andersen M; Palmisano G
    Proteomics; 2019 Nov; 19(21-22):e1900174. PubMed ID: 31576646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of serum protein biomarkers for prostate cancer progression by proteomic analysis.
    Al-Ruwaili JA; Larkin SE; Zeidan BA; Taylor MG; Adra CN; Aukim-Hastie CL; Townsend PA
    Cancer Genomics Proteomics; 2010; 7(2):93-103. PubMed ID: 20335524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proteome-based diagnostic and prognostic biomarkers of prostate cancer].
    Neuhaus J; Schiffer E; Siwy J; Mannello F; Horn LC; Stolzenburg JU
    Urologe A; 2013 Sep; 52(9):1251-5. PubMed ID: 24026060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Proteome of Primary Prostate Cancer.
    Iglesias-Gato D; Wikström P; Tyanova S; Lavallee C; Thysell E; Carlsson J; Hägglöf C; Cox J; Andrén O; Stattin P; Egevad L; Widmark A; Bjartell A; Collins CC; Bergh A; Geiger T; Mann M; Flores-Morales A
    Eur Urol; 2016 May; 69(5):942-52. PubMed ID: 26651926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease Expression Levels in Prostate Cancer Tissue Can Explain Prostate Cancer-Associated Seminal Biomarkers-An Explorative Concept Study.
    Neuhaus J; Schiffer E; Mannello F; Horn LC; Ganzer R; Stolzenburg JU
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28471417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of prostate cancer by analyzing oxidative stress in human seminal plasma: developing unsophisticated tools for noninvasive prostate cancer diagnosis.
    Barrio-Muñoz M; Abad-Gairín C; Amengual-Guedán JM; Prats-López J
    Eur J Cancer Prev; 2016 Nov; 25(6):518-23. PubMed ID: 26633164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of genital tract markers in the human seminal plasma using an integrative genomics approach.
    Rolland AD; Lavigne R; Dauly C; Calvel P; Kervarrec C; Freour T; Evrard B; Rioux-Leclercq N; Auger J; Pineau C
    Hum Reprod; 2013 Jan; 28(1):199-209. PubMed ID: 23024119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Database-augmented Mass Spectrometry Analysis of Exosomes Identifies Claudin 3 as a Putative Prostate Cancer Biomarker.
    Worst TS; von Hardenberg J; Gross JC; Erben P; Schnölzer M; Hausser I; Bugert P; Michel MS; Boutros M
    Mol Cell Proteomics; 2017 Jun; 16(6):998-1008. PubMed ID: 28396511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multigene methylation analysis for detection and staging of prostate cancer.
    Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Clin Cancer Res; 2005 Sep; 11(18):6582-8. PubMed ID: 16166436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semen as a rich source of diagnostic biomarkers for prostate cancer: latest evidence and implications.
    Mao C; Ding Y; Xu N
    Mol Cell Biochem; 2022 Jan; 477(1):213-223. PubMed ID: 34655417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PBOV1 as a potential biomarker for more advanced prostate cancer based on protein and digital histomorphometric analysis.
    Carleton NM; Zhu G; Gorbounov M; Miller MC; Pienta KJ; Resar LMS; Veltri RW
    Prostate; 2018 May; 78(7):547-559. PubMed ID: 29520928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patients.
    Tsaur I; Thurn K; Juengel E; Gust KM; Borgmann H; Mager R; Bartsch G; Oppermann E; Ackermann H; Nelson K; Haferkamp A; Blaheta RA
    J Exp Clin Cancer Res; 2015 May; 34(1):43. PubMed ID: 25967040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.